Filters
reset allOther countries
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
High-Resolution Rapid Microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Rapid microarray (CGH and SNP) Allele Diagnostics United States | 247 | 231 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
IL1RAPL1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Invitae Neurodevelopmental Disorders Panel Invitae United States | 404 | 241 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
X-linked Intellectual Disability via the IL1RAPL1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
X-Linked Intellectual Disability Panel PreventionGenetics, part of Exact Sciences United States | 191 | 141 |
|
X-chromosome High Resolution microarray analysis Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 240 | 171 |
|
X-Linked Mental Retardation Types 21/34 (IL1RAPL1) Center for Human Genetics, Inc United States | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5127 | 4672 |
|
XLID (X-Linked Intellectual Disability) NGS Panel Fulgent Genetics United States | 162 | 117 |
|
Intellectual Disability NGS Panel Fulgent Genetics United States | 1057 | 554 |
|
Fulgent Genetics United States | 170 | 106 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.